Other
Other comprehensive income/(loss)
West Pharmaceutical Services Other comprehensive income/(loss) decreased by 44.9% to -$19.70M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 137.5%, from $52.60M to -$19.70M.
Analysis
StatementIncome Statement
SectionOther
CategoryOther
SignalContext dependent
VolatilityVolatile
First reportedQ1 2019
Last reportedQ1 2026Apr 23, 2026
How to read this metric
Large fluctuations may indicate exposure to currency volatility or changes in the fair value of long-term assets.
Detailed definition
The total change in equity during the period resulting from transactions and other events from non-owner sources that ar...
Peer comparison
Commonly analyzed to understand the total economic impact on shareholder equity beyond net income.
Metric ID:
other_other_comprehensive_income_loss_net_of_tax_portion_aec37bHistorical Data
15 periods
| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $7.00M | -$22.50M | -$22.80M | -$63.50M | -$62.60M | $14.60M | -$15.10M | -$39.50M | -$48.50M | -$24.60M | $80.60M | $52.60M | $116.80M | -$13.60M | -$19.70M |
| QoQ Change | — | -421.4% | -1.3% | -178.5% | +1.4% | +123.3% | -203.4% | -161.6% | -22.8% | +49.3% | +427.6% | -34.7% | +122.1% | -111.6% | -44.9% |
| YoY Change | — | — | — | <-999% | -178.2% | +164.0% | +76.2% | +36.9% | -432.2% | -62.9% | +304.1% | +208.5% | +574.8% | -116.9% | -137.5% |
Range-$63.50M – $116.80M
CAGR+34.4%
Avg YoY Growth-47.5%
Median YoY Growth-13.0%
Current Streak2 quarters decline
Other comprehensive income/(loss) at Other Companies
Frequently Asked Questions
- What is West Pharmaceutical Services's other comprehensive income/(loss)?
- West Pharmaceutical Services (WST) reported other comprehensive income/(loss) of -$19.70M in Q1 2026.
- How has West Pharmaceutical Services's other comprehensive income/(loss) changed year-over-year?
- West Pharmaceutical Services's other comprehensive income/(loss) decreased by 137.5% year-over-year, from $52.60M to -$19.70M.
- What does other comprehensive income/(loss) mean?
- Gains or losses that bypass the income statement and go directly to equity.